STX107

· Seaside Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STX107, covering 2010-02-08 to 2012-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome [Phase 2]